Allogene Therapeutics, Inc. - Common Stock (ALLO)
CUSIP: 019770106
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 228,416,724
- Total 13F shares
- 165,184,059
- Share change
- +33,803,300
- Total reported value
- $384,891,280
- Put/Call ratio
- 118%
- Price per share
- $2.33
- Number of holders
- 169
- Value change
- +$75,138,227
- Number of buys
- 90
- Number of sells
- 58
Quarterly Holders Quick Answers
What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 019770106:
Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
25,363,798
|
$113,376,177 | — | 31 Mar 2024 | |
| TPG GP A, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
8.2%
|
18,716,306
|
$83,661,888 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.2%
|
9,652,930
|
$43,148,598 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
9,184,011
|
$41,052,529 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
8,207,564
|
$36,687,811 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2.4%
|
5,448,386
|
$24,354,285 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
5,181,979
|
$23,163,447 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
4,177,619
|
$18,675,000 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
3,850,000
|
$17,209,500 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
3,113,225
|
$13,916,116 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.3%
|
2,867,750
|
$12,818,843 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.2%
|
2,633,976
|
$11,773,873 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
2,371,334
|
$10,601,801 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
2,231,964
|
$9,976,878 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.89%
|
2,043,619
|
$9,134,977 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.84%
|
1,911,338
|
$8,543,681 | — | 31 Mar 2024 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
0.79%
|
1,798,163
|
$8,037,789 | — | 31 Mar 2024 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.84%
|
1,920,787
|
$7,877,861 | — | 31 Mar 2024 | |
| Eric Thomas Schmidt |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
2,447,772
mixed-class rows
|
$6,396,524 | — | 22 Mar 2023 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.59%
|
1,350,000
|
$6,034,500 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.58%
|
1,331,100
|
$5,950,017 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.57%
|
1,294,646
|
$5,787,067 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.43%
|
990,703
|
$4,428,442 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.43%
|
971,067
|
$4,340,669 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.38%
|
858,476
|
$3,837,388 | — | 31 Mar 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.32%
|
742,114
|
$3,380,329 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.32%
|
720,000
|
$3,218,400 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.3%
|
678,229
|
$3,031,683 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.23%
|
521,249
|
$2,329,983 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.23%
|
519,201
|
$2,320,828 | — | 31 Mar 2024 | |
| Alison Moore |
3/4/5
|
Chief Technical Officer |
—
mixed-class rows
|
1,105,469
mixed-class rows
|
$2,135,517 | — | 22 Mar 2023 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.2%
|
459,800
|
$2,055,305 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
437,436
|
$1,955,339 | — | 31 Mar 2024 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
0.19%
|
431,186
|
$1,927,401 | — | 31 Mar 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.19%
|
424,169
|
$1,896,035 | — | 31 Mar 2024 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.18%
|
406,847
|
$1,818,606 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
404,382
|
$1,807,588 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
396,900
|
$1,774,000 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.16%
|
361,913
|
$1,767,682 | — | 31 Mar 2024 | |
| Veer Bhavnagri |
3/4/5
|
General Counsel |
—
class O/S missing
|
556,049
|
$1,765,122 | — | 14 Mar 2023 | |
| Rafael Amado |
3/4/5
|
EVP of R&D |
—
class O/S missing
|
541,946
|
$1,720,353 | — | 07 Oct 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.13%
|
302,255
|
$1,351,080 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
300,553
|
$1,343,471 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.13%
|
286,408
|
$1,280,244 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.12%
|
282,150
|
$1,261,211 | — | 31 Mar 2024 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
0.1%
|
217,495
|
$972,203 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.09%
|
214,800
|
$960,156 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
201,470
|
$900,571 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.09%
|
198,412
|
$886,901 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.09%
|
195,778
|
$875,127 | — | 31 Mar 2024 |
Institutional Holders of Allogene Therapeutics, Inc. - Common Stock (ALLO) as of Q2 2024
As of 30 Jun 2024,
Allogene Therapeutics, Inc. - Common Stock (ALLO) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
165,184,059 shares.
The largest 10 holders included
FMR LLC, TPG GP A, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, Woodline Partners LP, and JPMORGAN CHASE & CO.
This page lists
170
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
158
Q2 2024 holders
169
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.